Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",glomerular filtration trait,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,168 days,19,,CMO:0001211,creatinine clearance to body weight ratio,,,,0.59,ml/min/100g,0.04,0.1744,MMO:0000270,blood creatinine analysis,,0.0,,,,,control condition,65378,control condition 309,"Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;.",glomerular filtration trait,,RS:0001373,MWF-Chr 6SHR/Rkb,female,168 days,20,,CMO:0001211,creatinine clearance to body weight ratio,,,,0.37,ml/min/100g,0.04,0.1789,MMO:0000270,blood creatinine analysis,,0.0,,,,,control condition,68182,control condition 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",kidney glomerulus quantity,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,28 days,7,,CMO:0000536,kidney glomerulus count,N(glom)=1/SSF x 1/ASF x Ps/Pf x ΣQ-/2,per kidney,,34600,,5700.0,15080.7825,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,,,,control condition,65398,control condition 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",blood triglyceride amount,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,168 days,19,,CMO:0000360,serum triglyceride level,,,,108.85008,mg/dl,0.885,3.8575,MMO:0000136,serum triglyceride analysis,,0.0,serum triglyceride analysis,,,,control condition,65385,control condition 309,"Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;.",heart mass,,RS:0001373,MWF-Chr 6SHR/Rkb,female,168 days,20,,CMO:0000074,heart weight to body weight ratio,,,,3.08,g/kg,0.1,0.4472,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,12766,control condition 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",heart mass,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,168 days,19,,CMO:0000074,heart weight to body weight ratio,,,,2.47,g/kg,0.05,0.2179,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,65371,control condition 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",blood cholesterol amount,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,168 days,19,,CMO:0000363,serum total cholesterol level,,,,74.5173,mg/dl,2.3166,10.0978,MMO:0000132,serum total cholesterol measurement test,,0.0,serum triglyceride analysis,,,,control condition,65390,control condition 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",blood urea nitrogen amount,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,168 days,19,,CMO:0000587,serum urea nitrogen level,,,,21.0075,mg/dl,0.7003,3.0523,MMO:0000273,serum urea analysis,,0.0,serum urea analysis,,,,control condition,65380,control condition 309,"Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;.",blood urea nitrogen amount,,RS:0001373,MWF-Chr 6SHR/Rkb,female,168 days,20,,CMO:0000587,serum urea nitrogen level,,,,19.27088,mg/dl,0.6722,3.0063,MMO:0000274,serum urea nitrogen analysis,,0.0,,,,,control condition,68179,control condition 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",arterial blood pressure trait,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,173 days,19,,CMO:0000004,systolic blood pressure,,,,151,mmHg,1.6,6.9742,MMO:0000053,tail cuff piezoplethysmography,,0.0,12-18 recordings on 3 consecutive days,,,,control condition,11689,control condition 309,"Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;.",arterial blood pressure trait,,RS:0001373,MWF-Chr 6SHR/Rkb,female,168 days,20,,CMO:0000004,systolic blood pressure,,,,139,mmHg,1.6,7.1554,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition,68173,control condition 3141,"Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384.",arterial blood pressure trait,,RS:0001373,MWF-Chr 6SHR/Rkb,male,84 days,10,,CMO:0000004,systolic blood pressure,,,,151,mmHg,1.6,5.0596,MMO:0000031,tail cuff plethysmography,,0.0,,,,,control condition (for 0 hours),109287,control condition (for 0 hours) 309,"Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;.",kidney mass,,RS:0001373,MWF-Chr 6SHR/Rkb,female,168 days,20,,CMO:0000340,both kidneys wet weight to body weight ratio,,,,6.06,g/kg,0.16,0.7155,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,12764,control condition 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",kidney mass,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,168 days,19,,CMO:0000340,both kidneys wet weight to body weight ratio,,,,5.62,g/kg,0.18,0.7846,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,65365,control condition 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",urine albumin amount,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,56 days,19,,CMO:0000757,urine albumin excretion rate,,,,0.7,mg/d,0.1,0.4359,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,control condition,65272,control condition 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",urine albumin amount,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,98 days,19,,CMO:0000757,urine albumin excretion rate,,,,2.9,mg/d,3.5,15.2561,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,control condition,65274,control condition 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",urine albumin amount,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,168 days,19,,CMO:0000757,urine albumin excretion rate,,,,16.6,mg/d,15.2,66.2553,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,control condition,65276,control condition 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",urine albumin amount,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,98 days,19,,CMO:0000757,urine albumin excretion rate,,,,48.8,mg/d,41.7,181.7661,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,control condition,65420,control condition 309,"Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;.",urine albumin amount,,RS:0001373,MWF-Chr 6SHR/Rkb,female,168 days,N/A,,CMO:0000757,urine albumin excretion rate,,,,1.7,mg/d,,,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,control condition,69946,control condition 3141,"Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384.",vasodilation trait,,RS:0001373,MWF-Chr 6SHR/Rkb,male,84 days,10,,CMO:0000731,acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel,,,,64,%,3.8,12.0167,MMO:0000342,wire myography,,0.0,,,,,control condition (for 0 hours),109371,control condition (for 0 hours) 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",blood creatinine amount,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,168 days,19,,CMO:0000057,serum creatinine level,,,,0.42827,mg/dl,0.0181,0.0788,MMO:0000271,serum creatinine analysis,,0.0,,,,,control condition,65374,control condition 309,"Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;.",blood creatinine amount,,RS:0001373,MWF-Chr 6SHR/Rkb,female,168 days,20,,CMO:0000057,serum creatinine level,,,,0.47799,mg/dl,0.0124,0.0556,MMO:0000271,serum creatinine analysis,,0.0,,,,,control condition,68176,control condition 309,"Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;.",heart mass,,RS:0001373,MWF-Chr 6SHR/Rkb,female,168 days,20,,CMO:0000069,heart wet weight,,,,0.66,g,0.03,0.1342,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,12765,control condition 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",heart mass,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,168 days,19,,CMO:0000069,heart wet weight,,,,0.93,g,0.02,0.0872,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,65368,control condition 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",kidney mass,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,168 days,19,,CMO:0000085,both kidneys wet weight,,,,2.11,g,0.07,0.3051,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,65362,control condition 309,"Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;.",kidney mass,,RS:0001373,MWF-Chr 6SHR/Rkb,female,168 days,20,,CMO:0000085,both kidneys wet weight,,,,1.3,g,0.05,0.2236,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,68170,control condition 309,"Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;.",body mass,,RS:0001373,MWF-Chr 6SHR/Rkb,female,168 days,20,,CMO:0000012,body weight,,,,214.4,g,5.2,23.2551,MMO:0000016,body weighing method,,0.0,,,,,control condition,12759,control condition 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",kidney glomerulus quantity,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,168 days,19,,CMO:0001001,count of superficial glomeruli directly contacting the kidney surface,,per section,,1.6,,0.4,1.7436,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,,,,control condition,65460,control condition 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",kidney glomerulus quantity,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,168 days,19,,CMO:0001002,count of superficial glomeruli not directly contacting the kidney surface,,per section,,15.2,,1.1,4.7948,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,,,,control condition,65457,control condition 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",body mass,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,168 days,19,,CMO:0000012,body weight,,,,375,g,8.9,38.7942,MMO:0000016,body weighing method,,0.0,,,,,control condition,65359,control condition 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",urine albumin amount,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,168 days,19,,CMO:0000999,urine albumin level to urine low molecular weight protein ratio,,,,159,%,42.0,183.0738,MMO:0000100,gel electrophoresis,,0.0,,,,,control condition,65356,control condition 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",urine albumin amount,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,98 days,19,,CMO:0000999,urine albumin level to urine low molecular weight protein ratio,,,,950,%,55.0,239.7394,MMO:0000100,gel electrophoresis,,0.0,,,,,control condition,65357,control condition 3141,"Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384.",vasoconstriction trait,,RS:0001373,MWF-Chr 6SHR/Rkb,male,84 days,10,,CMO:0003727,negative logarithm of the molar concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value,,logarithm of the concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value (CMO:0003677),,8.1,,0.1,0.3162,MMO:0000342,wire myography,,0.0,,,,,control condition (for 0 hours),109386,control condition (for 0 hours) 3141,"Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384.",vasoconstriction trait,,RS:0001373,MWF-Chr 6SHR/Rkb,male,84 days,10,,CMO:0003726,norepinephrine-induced blood vessel contractile force expressed as percent of force of contraction to KCL,,norepinephrine-induced blood vessel contractile force expressed as percent of force at baseline (CMO:0003676),,128.2,%,17.0,53.7587,MMO:0000342,wire myography,,0.0,,,,,control condition (for 0 hours),109381,control condition (for 0 hours) 3145,"Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a.",body length,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,-6 days,12,,CMO:0003847,"body length, crown to rump",,"body length, crown to rump (CMO:0003847)",,13,mm,0.2887,1.0,MMO:0000209,body length measuring method,,0.0,,,,,control condition,109512,control condition 3145,"Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a.",body mass,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,-6 days,12,,CMO:0002080,fetal body weight,,,,0.27,g,0.0061,0.021,MMO:0000016,body weighing method,,0.0,,,,,control condition,109505,control condition 3145,"Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a.",body mass,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,-6 days,12,,CMO:0002080,fetal body weight,,,,0.265,g,0.0049,0.017,MMO:0000016,body weighing method,,0.0,,,,,control condition,109506,control condition 3145,"Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a.",ureteric bud morphology trait,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,-6 days,12,,CMO:0003848,number of ureteric bud tips per kidney,,number of ureteric bud tips per kidney (CMO:0003848),,64,,3.4641,12.0,MMO:0000686,immunofluorescence confocal microscopy,,0.0,immunofluorescence confocal microscopy with digital image analysis (MMO:0000751),,,,control condition,109518,control condition 3145,"Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a.",kidney glomerulus quantity,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,-6 days,12,,CMO:0003797,number of glomeruli per kidney,,,,37,,1.7321,6.0,MMO:0000686,immunofluorescence confocal microscopy,,0.0,immunofluorescence confocal microscopy with digital image analysis (MMO:0000751),,,,control condition,109515,control condition 3145,"Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a.",kidney glomerulus quantity,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,-6 days,12,,CMO:0003849,number of glomeruli per kidney to number of ureteric bud tips per kidney ratio,,number of glomeruli per kidney to number of ureteric bud tips per kidney ratio (CMO:0003849),,0.59,,0.0346,0.12,MMO:0000686,immunofluorescence confocal microscopy,,0.0,immunofluorescence confocal microscopy with digital image analysis (MMO:0000751),,,,control condition,109521,control condition